Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/07/2012EP2424864A1 Oxazole substituted indazoles as pi3-kinase inhibitors
03/07/2012EP2424863A1 Isoxazole derivatives
03/07/2012EP2424861A1 Indole-2-carboxamide derivative
03/07/2012EP2424860A1 Heteroarylthiomethyl pyridine derivative
03/07/2012EP2424859A1 Inhibitors of pi3 kinase and / or mtor
03/07/2012EP2424858A1 Cxcr3 receptor antagonists
03/07/2012EP2424856A1 Fused heterocyclic compound and use thereof
03/07/2012EP2424854A2 Compositions and methods for treatment of cardiovascular disease
03/07/2012EP2424853A2 Non-steroidal compounds for androgen receptor modulation, processes for the preparation and uses thereof
03/07/2012EP2424850A1 Benzamide and naphthamide derivatives inhibiting nuclear factor- kap pa (b) - (nf-kb)
03/07/2012EP2424849A1 Salt of abt-263 and solid-state forms thereof
03/07/2012EP2424847A1 Processes for the preparation of rivaroxaban and intermediates thereof
03/07/2012EP2424844A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
03/07/2012EP2424843A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
03/07/2012EP2424842A2 Dual mechanism inhibitors for the treatment of disease
03/07/2012EP2424841A1 Pyridinone antagonists of alpha-4 integrins
03/07/2012EP2424840A1 Cxcr3 receptor antagonists
03/07/2012EP2424838A1 Pesticidal arylpyrrolidines
03/07/2012EP2424836A2 A process for isolation of lutein and zeaxanthin crystals from plant sources
03/07/2012EP2424829A2 Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor
03/07/2012EP2424568A1 Cannabinoid-containing compositions and methods for their use
03/07/2012EP2424559A1 Methods of treating bacterial infections using oritavancin
03/07/2012EP2424551A1 Use of collinsella aerofaciens for reducing bloating
03/07/2012EP2424549A1 Compositions and methods for treating or preventing urolithiasis and conditions associated therewith
03/07/2012EP2424547A1 Methods of treatment utilising glucan formulations
03/07/2012EP2424546A1 Method of reducing intraocular pressure in humans
03/07/2012EP2424545A1 Natural molecules extracted from bergamot tissues, extraction process and pharmaceutical use
03/07/2012EP2424544A1 Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
03/07/2012EP2424543A1 Chemical process
03/07/2012EP2424542A1 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
03/07/2012EP2424541A2 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
03/07/2012EP2424540A1 Compositions and methods for treating and preventing overactive bladder and conditions associated therewith
03/07/2012EP2424539A1 Method of treatment of depression
03/07/2012EP2424538A1 Use of allopurinol for the treatment of hand foot skin reaction
03/07/2012EP2424537A1 Substituted imidazoquinoxalines
03/07/2012EP2424536A2 Novel photosensitizer formulations for oral administration
03/07/2012EP2424535A2 Methods and compositions for treating dry eye
03/07/2012EP2424534A2 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
03/07/2012EP2424533A1 Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
03/07/2012EP2424532A1 Compounds for inducing cellular apoptosis
03/07/2012EP2424531A2 Irak kinase family as novel target and biomarker for alzheimer
03/07/2012EP2424530A2 Method and composition for treating diabetic ketoacidosis
03/07/2012EP2424529A2 Novel therapeutic treatments using centhaquin
03/07/2012EP2424528A2 Treatment of osteoarthritis pain
03/07/2012EP2424527A1 Mast cell stabilizers to prevent or treat laminitis
03/07/2012EP2424526A1 A pharmaceutical, dermatological, nutritional or cosmetic composition for combating the immunosuppressive action of aggressive agents on the skin
03/07/2012EP2424525A1 Formulations of cannabidiol and methods of using the same
03/07/2012EP2424524A1 Treatment or prophylaxis of proliferative conditions
03/07/2012EP2424523A1 Sublingual spray formulation comprising dihydroartemesinin
03/07/2012EP2424522A1 Composition for removing atheromatous plaque
03/07/2012EP2424521A2 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
03/07/2012EP2424520A1 Use of pufas for treating skin inflammation
03/07/2012EP2424519A1 Use of pufas to treat nerve damage
03/07/2012EP2424518A1 Oral compositions for skin benefits
03/07/2012EP2424517A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
03/07/2012EP2424516A2 Pentamidine combinations for treating cancer
03/07/2012EP2424515A1 N omega-hydroxy-l-arginine derivatives for the treatment of diseases
03/07/2012EP2424514A1 Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
03/07/2012EP2424513A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
03/07/2012EP2424512A1 Methods and compositions for improving the health of animals
03/07/2012EP2424511A1 Prevention and treatment of sarcopenia
03/07/2012EP2424507A1 Compositions and methods for treating insulin resistance and diabetes mellitus
03/07/2012EP2424506A1 Oral formulations of bendamustine
03/07/2012EP2424505A2 Multicomponent bioactive intravaginal ring
03/07/2012EP2424504A2 Orally disintegrating tablet compositions comprising combinations of high and low-dose drugs
03/07/2012EP2424502A1 Compositions containing a mixture of lutein and zeaxanthine and coated with chocolate
03/07/2012EP2424500A1 Lipid formulation of apoptosis promoter
03/07/2012EP2424499A1 Stabilized lipid formulation of apoptosis promoter
03/07/2012EP2424498A1 Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
03/07/2012EP2424497A2 Intraocular bioactive agent delivery compositon including a molecular partitioning system
03/07/2012EP2424495A1 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
03/07/2012EP2424494A1 Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
03/07/2012EP2424375A2 Antiviral fiber assembly with cellulose sulfate
03/07/2012EP2424368A1 Pyrrolotriazine compounds
03/07/2012EP2424366A1 Pyrido [4, 3-b]indoles and methods of use
03/07/2012EP2424365A1 Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics
03/07/2012EP2424364A1 Pyrido [4,3-b] indoles and methods of use
03/07/2012EP2424363A1 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
03/07/2012EP2424360A1 Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
03/07/2012EP2424359A1 Polymer micelles containing anthracylines for the treatment of cancer
03/07/2012EP2424357A1 Treatment of neurodegeneration and neuroinflammation
03/07/2012EP2424356A1 Stable pharmaceutical composition and methods of using same
03/07/2012EP2424354A2 Moisturizing antimicrobial composition
03/07/2012EP2424351A1 Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
03/07/2012EP2234985B1 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
03/07/2012EP2229149B1 Process for recovering flunixin from pharmaceutical compositions
03/07/2012EP2213674B1 Purification method of pemetrexed salts,sodium salts and disodium salts
03/07/2012EP2207786B1 2'-fluoro-2'-deoxytetrahydrouridines as cytidine deaminase inhibitors
03/07/2012EP2201002B1 5-ht7 receptor antagonists
03/07/2012EP2188253B1 Indol-2-one derivatives disubstituted in 3-position, preparation thereof and therapeutic use thereof
03/07/2012EP2175859B1 Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
03/07/2012EP2142215B1 Combination therapy for the treatment of hcv infection
03/07/2012EP2137180B1 Dibenzo [b,f][1,4] oxazapine compounds
03/07/2012EP2111402B1 Aminopyrazole kinase inhibitors
03/07/2012EP2100895B1 Tricyclic compound and medical use thereof
03/07/2012EP2080512B1 Anti-cancer agent
03/07/2012EP2066312B1 Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases
03/07/2012EP1982986B1 Pyrrolopyridazinone compound as pde4 inhibitor
03/07/2012EP1979331B1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
03/07/2012EP1962850B1 Treatment of drug-resistant tumors
1 ... 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 ... 7860